{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:25:12Z","timestamp":1786551912514,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20200109140603831"],"award-info":[{"award-number":["JCYJ20200109140603831"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["KQTD20180412181221912"],"award-info":[{"award-number":["KQTD20180412181221912"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["ZDKJ20190305003"],"award-info":[{"award-number":["ZDKJ20190305003"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.omto.2022.12.002","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T02:10:27Z","timestamp":1670379027000},"page":"182-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["A cancer cell membrane coated, doxorubicin and microRNA co-encapsulated nanoplatform for colorectal cancer theranostics"],"prefix":"10.1016","volume":"28","author":[{"given":"Sihao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongye","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanye","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3301-9085","authenticated-orcid":false,"given":"Qiushi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2022.12.002_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2017.99","article-title":"Non-coding RNA networks in cancer","volume":"18","author":"Anastasiadou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2022.12.002_bib2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cell.2020.09.017","article-title":"A MicroRNA linking human positive selection and metabolic disorders","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omto.2022.12.002_bib3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature10323","article-title":"MicroRNA-mediated conversion of human fibroblasts to neurons","volume":"476","author":"Yoo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.omto.2022.12.002_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omto.2022.12.002_bib5","doi-asserted-by":"crossref","first-page":"21454","DOI":"10.1002\/anie.202009263","article-title":"A near-infrared photo-switched MicroRNA amplifier for precise photodynamic therapy of early-stage cancers","volume":"59","author":"Zhang","year":"2020","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.omto.2022.12.002_bib6","doi-asserted-by":"crossref","first-page":"32493","DOI":"10.1021\/acsami.0c09494","article-title":"Dual MicroRNA-triggered drug release system for combined chemotherapy and gene therapy with logic operation","volume":"12","author":"Yue","year":"2020","journal-title":"ACS Appl. Mater. Inter."},{"key":"10.1016\/j.omto.2022.12.002_bib7","first-page":"1","article-title":"Cancer statistics: updated cancer burden in China Preface","volume":"27","author":"Chen","year":"2015","journal-title":"Chin. J Cancer Res"},{"key":"10.1016\/j.omto.2022.12.002_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00000658-198703000-00008","article-title":"Patterns of failure following surgical resection of colorectal-cancer liver metastases - rationale for a multimodal approach","volume":"205","author":"Bozzetti","year":"1987","journal-title":"Ann. Surg."},{"key":"10.1016\/j.omto.2022.12.002_bib9","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/0929867324666170111152436","article-title":"Colorectal cancer chemotherapy: the evolution of treatment and new approaches","volume":"24","author":"McQuade","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.omto.2022.12.002_bib10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00280-010-1386-x","article-title":"Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin","volume":"67","author":"Effenberger-Neidnicht","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.omto.2022.12.002_bib11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0140-6736(15)01088-0","article-title":"Antiangiogenic therapy in oncology: current status and future directions","volume":"388","author":"Jayson","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.omto.2022.12.002_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","article-title":"Cyclooxygenase regulates angiogenesis induced by colon cancer cells","volume":"93","author":"Tsujii","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.omto.2022.12.002_bib13","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.omto.2022.12.002_bib14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cell.2009.12.046","article-title":"Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development","volume":"140","author":"Lichtenberger","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.omto.2022.12.002_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","article-title":"The great escape: tumour cell plasticity in resistance to targeted therapy","volume":"19","author":"Boumahdi","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omto.2022.12.002_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ijc.28686","article-title":"Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts","volume":"135","author":"Miyazaki","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omto.2022.12.002_bib17","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/annonc\/mdn540","article-title":"Reversible tumor growth acceleration following bevacizumab interruption in metastatic colorectal cancer patients scheduled for surgery","volume":"19","author":"Cacheux","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.omto.2022.12.002_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","article-title":"Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis","volume":"15","author":"P\u00e0ez-Ribes","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omto.2022.12.002_bib19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1261\/rna.044651.114","article-title":"The synergistic regulation of VEGF-mediated angiogenesis through miR-190 and target genes","volume":"20","author":"Hao","year":"2014","journal-title":"RNA"},{"key":"10.1016\/j.omto.2022.12.002_bib20","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1038\/s41388-018-0378-x","article-title":"Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?","volume":"37","author":"van Staalduinen","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.omto.2022.12.002_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature16064","article-title":"Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer","volume":"527","author":"Zheng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omto.2022.12.002_bib22","doi-asserted-by":"crossref","first-page":"e1901081","DOI":"10.1002\/adma.201901081","article-title":"Cancer-targeting nanoparticles for combinatorial nucleic acid delivery","volume":"32","author":"Vaughan","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omto.2022.12.002_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2016.03.026","article-title":"Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy","volume":"92","author":"Ren","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.omto.2022.12.002_bib24","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1021\/acsnano.5b01042","article-title":"Erythrocyte membrane-enveloped polymeric nanoparticles as nanovaccine for induction of antitumor immunity against melanoma","volume":"9","author":"Guo","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.omto.2022.12.002_bib25","doi-asserted-by":"crossref","first-page":"47330","DOI":"10.1021\/acsami.0c15419","article-title":"Leukocyte-mediated combined targeted chemo and gene therapy for esophageal cancer","volume":"12","author":"Jun","year":"2020","journal-title":"ACS Appl. Mater. Inter."},{"key":"10.1016\/j.omto.2022.12.002_bib26","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/acs.bioconjchem.0c00518","article-title":"Portfolio targeting strategy to realize the assembly and membrane fusion-mediated delivery of gold nanoparticles to mitochondria for enhanced NIR photothermal therapies","volume":"31","author":"Ning","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omto.2022.12.002_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","article-title":"Strategies, design, and chemistry in siRNA delivery systems","volume":"144","author":"Dong","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omto.2022.12.002_bib28","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1021\/acsnano.6b07195","article-title":"Multifunctional envelope-type siRNA delivery nanoparticle platform for prostate cancer therapy","volume":"11","author":"Xu","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.omto.2022.12.002_bib29","doi-asserted-by":"crossref","first-page":"e1706759","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omto.2022.12.002_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/acs.bioconjchem.6b00569","article-title":"Biointerfacing and applications of cell membrane-coated nanoparticles","volume":"28","author":"Kroll","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omto.2022.12.002_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2015.12.015","article-title":"PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery","volume":"240","author":"Cho","year":"2016","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.omto.2022.12.002_bib32","doi-asserted-by":"crossref","first-page":"33412","DOI":"10.1021\/acsami.6b08153","article-title":"Gemcitabine and antisense-microRNA Co-encapsulated PLGA-PEG polymer nanoparticles for hepatocellular carcinoma therapy","volume":"8","author":"Devulapally","year":"2016","journal-title":"ACS Appl. Mater. Inter."},{"key":"10.1016\/j.omto.2022.12.002_bib33","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1038\/s41598-018-25930-7","article-title":"PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer","volume":"8","author":"Risnayanti","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omto.2022.12.002_bib34","doi-asserted-by":"crossref","first-page":"eabd6889","DOI":"10.1126\/sciadv.abd6889","article-title":"BBB pathophysiology-independent delivery of siRNA in traumatic brain injury","volume":"7","author":"Li","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omto.2022.12.002_bib35","doi-asserted-by":"crossref","first-page":"128ra39","DOI":"10.1126\/scitranslmed.3003651","article-title":"Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile","volume":"4","author":"Hrkach","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omto.2022.12.002_bib36","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1182\/bloodadvances.2020001658","article-title":"Processing methods and storage duration impact extracellular vesicle counts in red blood cell units","volume":"4","author":"Gamonet","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.omto.2022.12.002_bib37","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.omto.2022.12.002_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.aac9935","article-title":"MYC regulates the antitumor immune response through CD47 and PD-L1","volume":"352","author":"Casey","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omto.2022.12.002_bib39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1126\/science.274.5288.795","article-title":"Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice","volume":"274","author":"Lindberg","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.omto.2022.12.002_bib40","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1229568","article-title":"Minimal \"self\" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles","volume":"339","author":"Rodriguez","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omto.2022.12.002_bib41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1238856","article-title":"Engineered SIRP alpha variants as immunotherapeutic adjuvants to anticancer antibodies","volume":"341","author":"Weiskopf","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omto.2022.12.002_bib42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omto.2022.12.002_bib43","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/jcm8091269","article-title":"Systematic evaluation of light-activatable biohybrids for anti-glioma photodynamic therapy","volume":"8","author":"Inglut","year":"2019","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.omto.2022.12.002_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2016.11.005","article-title":"Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer","volume":"244","author":"Xiong","year":"2016","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.omto.2022.12.002_bib45","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1021\/nn507465d","article-title":"Polymer nanoparticles mediated codelivery of AntimiR-10b and AntimiR-21 for achieving triple negative breast cancer therapy","volume":"9","author":"Devulapally","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.omto.2022.12.002_bib46","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1021\/nn400334y","article-title":"Single-step assembly of DOX\/ICG loaded lipid-polymer nanoparticles for highly effective chemo-photothermal combination therapy","volume":"7","author":"Zheng","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.omto.2022.12.002_bib47","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1038\/s41467-019-12142-4","article-title":"Near-infrared light and tumor microenvironment dual responsive size-switchable nanocapsules for multimodal tumor theranostics","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omto.2022.12.002_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nm.1854","article-title":"Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes","volume":"15","author":"Urano","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.omto.2022.12.002_bib49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc3110","article-title":"Dysregulated pH: a perfect storm for cancer progression","volume":"11","author":"Webb","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2022.12.002_bib50","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1166\/jbn.2009.1038","article-title":"Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer","volume":"5","author":"Prajakta","year":"2009","journal-title":"J.\u00a0Biomed. Nanotechnol."},{"key":"10.1016\/j.omto.2022.12.002_bib51","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/S0142-9612(00)00115-0","article-title":"The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices","volume":"21","author":"Jain","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.omto.2022.12.002_bib52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0168-3659(98)00030-3","article-title":"Plasma protein adsorption on biodegradable microspheres consisting of poly(D, L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition","volume":"55","author":"L\u00fcck","year":"1998","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.omto.2022.12.002_bib53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Shive","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omto.2022.12.002_bib54","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.apsb.2020.10.005","article-title":"Small interfering RNA for cancer treatment: overcoming hurdles in delivery","volume":"10","author":"Charbe","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.omto.2022.12.002_bib55","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.gt.3301506","article-title":"On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids","volume":"8","author":"Hafez","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.omto.2022.12.002_bib56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/smll.200901158","article-title":"Effect of surface properties on nanoparticle-cell interactions","volume":"6","author":"Verma","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.omto.2022.12.002_bib57","doi-asserted-by":"crossref","first-page":"7850","DOI":"10.1021\/acsami.8b22309","article-title":"Human cancer cell membrane-coated biomimetic nanoparticles reduce fibroblast-mediated invasion and metastasis and induce T-cells","volume":"11","author":"Jin","year":"2019","journal-title":"ACS Appl. Mater. Inter."},{"key":"10.1016\/j.omto.2022.12.002_bib58","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41587-020-0707-9","article-title":"Mitochondrial copper depletion suppresses triple-negative breast cancer in mice","volume":"39","author":"Cui","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omto.2022.12.002_bib59","doi-asserted-by":"crossref","first-page":"9581","DOI":"10.1002\/adma.201602173","article-title":"Cancer-cell-biomimetic nanoparticles for targeted therapy of homotypic tumors","volume":"28","author":"Sun","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omto.2022.12.002_bib60","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nature08062","article-title":"Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1","volume":"459","author":"Baek","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.omto.2022.12.002_bib61","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","article-title":"Angiogenesis in life, disease and medicine","volume":"438","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.omto.2022.12.002_bib62","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/22788","article-title":"Essential role for oncogenic Ras in tumour maintenance","volume":"400","author":"Chin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.omto.2022.12.002_bib63","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target","volume":"438","author":"Ferrara","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.omto.2022.12.002_bib64","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/s41598-018-37862-3","article-title":"Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration","volume":"9","author":"Abdullah","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omto.2022.12.002_bib65","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41556-018-0256-3","article-title":"Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models","volume":"21","author":"Keklikoglou","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omto.2022.12.002_bib66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","article-title":"TGFbeta biology in cancer progression and immunotherapy","volume":"18","author":"Derynck","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omto.2022.12.002_bib67","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12964-018-0304-4","article-title":"Chemotherapy-driven increases in the CDKN1A\/PTN\/PTPRZ1 axis promote chemoresistance by activating the NF-kappaB pathway in breast cancer cells","volume":"16","author":"Huang","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.omto.2022.12.002_bib68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/bs.acr.2018.11.001","article-title":"Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy","volume":"141","author":"Xiang","year":"2019","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.omto.2022.12.002_bib69","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12935-019-0984-x","article-title":"miR-190-5p in human diseases","volume":"19","author":"Yu","year":"2019","journal-title":"Cancer Cell Int."}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770522001449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770522001449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:26:13Z","timestamp":1762496773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770522001449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":69,"alternative-id":["S2372770522001449"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2022.12.002","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cancer cell membrane coated, doxorubicin and microRNA co-encapsulated nanoplatform for colorectal cancer theranostics","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2022.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}]}}